DOI:
10.1055/s-00000071
Seminars in Neurology
LinksClose Window
References
Harrington C, Sawchak S, Chiang C , et al.
Rosiglitazone does not improve cognition or global function when used as adjunctive therapy to AChE inhibitors in mild-to-moderate Alzheimer's disease: two phase 3 studies.
Curr Alzheimer Res 2011;
8 (5) 592-606
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.